A. Marie O'Farrell

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12‐week, double‐blind, randomized, placebo‐controlled, multicentre trial

H.M. Rodriquez Pattzi, Shailesh Pitale, Cavan Bennett et al. · Diabetes Obesity and Metabolism · 2010 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects

A. Marie O'Farrell, André van Vliet, Khalid Abou Farha et al. · Clinical Therapeutics · 2007 · 31 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

The dipeptidyl peptidase‐4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus

G. Garcia‐Soria, Guillermo González-Gálvez, G. M. Argoud et al. · Diabetes Obesity and Metabolism · 2008 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Studies of the Isolated Perfused Ovary: Methods and Examples of Application

Elijah B. Romanoff, Gregory Pincus, FOSTER BURNETT et al. · Endocrinology · 1962 · 22 citations

Medicine, Animal Sciences, Veterinary Physiology +4

Pharmacokinetics and Antiviral Activity of Phx1766, a Novel HCV Protease Inhibitor, Using An Accelerated Phase I Study Design

Daphne M. Hotho, Joep de Bruijne, A. Marie O'Farrell et al. · Antiviral Therapy · 2011 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13